2-deoxy-D-glucose

DRUG2 trials

Sponsors

G.ST Antivirals GmbH, G.ST Antivirals GmbH, G.ST Antivirals GmbH

Conditions

Acute NasopharyngitisRhinovirus-associated illness

Phase 2

A randomized, double-blind, placebo-controlled Phase 2 study using the rhinovirus challenge model to investigate the efficacy and safety of 2-Deoxy-D-glucose as pre-exposure prophylaxis.

CompletedCTIS2023-509311-91-01

G.ST Antivirals GmbH, G.ST Antivirals GmbHRhinovirus-associated illness

Start: 2024-02-15End: 2024-08-13Target: 128Updated: 2024-02-14

A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults

TerminatedNCT06375772

G.ST Antivirals GmbHAcute Nasopharyngitis

Start: 2024-04-02End: 2024-08-13Updated: 2024-11-19